XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock Series A
Preferred Stock Series A-1
Preferred Stock Series B
Preferred Stock Series B-1
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]   $ 9,569 $ 14,083 $ 18,854 $ 4,682      
Beginning balance (in shares) at Dec. 31, 2020 [1]   26,157,622 20,238,201 12,366,306 3,047,183      
Ending balance (in shares) at Mar. 31, 2021 [1]   26,157,622 20,238,201 12,366,306 3,047,183      
Ending balance at Mar. 31, 2021 [1]   $ 9,569 $ 14,083 $ 18,854 $ 4,682      
Beginning balance (in shares) at Dec. 31, 2020 [1]           22,118,619    
Beginning balance at Dec. 31, 2020 $ (68,009)         $ 2 [1] $ 3,707 $ (71,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares) [1]           367,432    
Issuance of common stock upon exercise of stock options 244           244  
Share-based compensation 828           828  
Net loss (7,857)             (7,857)
Ending balance (in shares) at Mar. 31, 2021 [1]           22,486,051    
Ending balance at Mar. 31, 2021 (74,794)         $ 2 [1] 4,779 (79,575)
Beginning balance (in shares) at Dec. 31, 2020 [1]   26,157,622 20,238,201 12,366,306 3,047,183      
Ending balance (in shares) at Sep. 30, 2021   0 0 0 0      
Ending balance at Sep. 30, 2021   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Dec. 31, 2020 [1]           22,118,619    
Beginning balance at Dec. 31, 2020 (68,009)         $ 2 [1] 3,707 (71,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (47,647)              
Ending balance (in shares) at Sep. 30, 2021           112,818,724    
Ending balance at Sep. 30, 2021 76,975         $ 11 196,330 (119,366)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]   $ 9,569 $ 14,083 $ 18,854 $ 4,682      
Beginning balance (in shares) at Mar. 31, 2021 [1]   26,157,622 20,238,201 12,366,306 3,047,183      
Ending balance (in shares) at Jun. 30, 2021 [1]   26,157,622 20,238,201 12,366,306 3,047,183      
Ending balance at Jun. 30, 2021 [1]   $ 9,569 $ 14,083 $ 18,854 $ 4,682      
Beginning balance (in shares) at Mar. 31, 2021 [1]           22,486,051    
Beginning balance at Mar. 31, 2021 (74,794)         $ 2 [1] 4,779 (79,575)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares) [1]           63,004    
Issuance of common stock upon exercise of stock options 24           24  
Share-based compensation 785           785  
Net loss (5,335)             (5,335)
Ending balance (in shares) at Jun. 30, 2021 [1]           22,549,055    
Ending balance at Jun. 30, 2021 (79,320)         $ 2 [1] 5,588 (84,910)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]   $ 9,569 $ 14,083 $ 18,854 $ 4,682      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)   (26,157,622) (20,238,201) (12,366,306) (3,047,183)      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (Note 2)   $ (9,569) $ (14,803) $ (18,854) $ (4,682)      
Ending balance (in shares) at Sep. 30, 2021   0 0 0 0      
Ending balance at Sep. 30, 2021   $ 0 $ 0 $ 0 $ 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)           61,809,312    
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 47,188         $ 6 47,182  
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (in shares)           4,633,507    
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (Note 2) 7,122         $ 1 7,121  
Beneficial conversion feature of convertible promissory notes in connection with the reverse recapitalization (Note 2) 26,061           26,061  
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization (in shares)           1,771,231    
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization (Note 2) 8,571           8,571  
Reverse recapitalization transaction, net of fees (in shares)           21,959,227    
Reverse recapitalization transaction, net of fees 101,035         $ 2 101,033  
Issuance of common stock upon exercise of stock options (in Shares)           96,392    
Issuance of common stock upon exercise of stock options 77           77  
Share-based compensation 697           697  
Net loss (34,456)             (34,456)
Ending balance (in shares) at Sep. 30, 2021           112,818,724    
Ending balance at Sep. 30, 2021 76,975         $ 11 196,330 (119,366)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance   0 0 0 0      
Beginning balance [1]   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Dec. 31, 2021 [1]   0 0 0 0      
Ending balance (in shares) at Mar. 31, 2022 [1]   0 0 0 0      
Ending balance at Mar. 31, 2022 [1]   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Dec. 31, 2021 [1]           112,996,568    
Beginning balance at Dec. 31, 2021 55,191         $ 11 [1] 198,602 (143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares) [1]           88,808    
Issuance of common stock upon exercise of stock options 48           48  
Issuance of common stock for restricted stock units vesting (in shares) [1]           321,098    
Share-based compensation 3,336           3,336  
Net loss (28,758)             (28,758)
Ending balance (in shares) at Mar. 31, 2022 [1]           113,406,474    
Ending balance at Mar. 31, 2022 29,817         $ 11 [1] 201,986 (172,180)
Beginning balance (in shares) at Dec. 31, 2021 [1]   0 0 0 0      
Ending balance (in shares) at Sep. 30, 2022   0 0 0 0      
Ending balance at Sep. 30, 2022   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Dec. 31, 2021 [1]           112,996,568    
Beginning balance at Dec. 31, 2021 55,191         $ 11 [1] 198,602 (143,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (59,838)              
Ending balance (in shares) at Sep. 30, 2022           114,852,448    
Ending balance at Sep. 30, 2022 4,419         $ 11 207,668 (203,260)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Mar. 31, 2022 [1]   0 0 0 0      
Ending balance (in shares) at Jun. 30, 2022 [1]   0 0 0 0      
Ending balance at Jun. 30, 2022 [1]   $ 0 $ 0 $ 0 $ 0      
Beginning balance (in shares) at Mar. 31, 2022 [1]           113,406,474    
Beginning balance at Mar. 31, 2022 29,817         $ 11 [1] 201,986 (172,180)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares) [1]           418,126    
Issuance of common stock upon exercise of stock options 166           166  
Issuance of common stock for restricted stock units vesting (in shares) [1]           230,361    
Share-based compensation 3,273           3,273  
Net loss (11,718)             (11,718)
Ending balance (in shares) at Jun. 30, 2022 [1]           114,054,961    
Ending balance at Jun. 30, 2022 21,538         $ 11 [1] 205,425 (183,898)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance [1]   $ 0 $ 0 $ 0 $ 0      
Ending balance (in shares) at Sep. 30, 2022   0 0 0 0      
Ending balance at Sep. 30, 2022   $ 0 $ 0 $ 0 $ 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares)           305,006    
Issuance of common stock upon exercise of stock options 41           41  
Issuance of common stock for restricted stock units vesting (in shares)           242,592    
Issuance of common stock for employee stock purchase plan (in shares)           249,889    
Issuance of common stock for employee stock purchase plan 359           359  
Share-based compensation 1,843           1,843  
Net loss (19,362)             (19,362)
Ending balance (in shares) at Sep. 30, 2022           114,852,448    
Ending balance at Sep. 30, 2022 $ 4,419         $ 11 $ 207,668 $ (203,260)
Increase (Decrease) in Temporary Equity [Roll Forward]                
Beginning balance   $ 0 $ 0 $ 0 $ 0      
[1] The shares of the Company’s common and redeemable convertible preferred stock, prior to the merger with Sandbridge Acquisition Corporation on July 15, 2021 have been retrospectively adjusted as shares reflecting the exchange ratio of approximately 2.053 established in the Merger.